Tenaya Therapeutics (TNYA) Gains from Investment Securities (2020 - 2026)
Tenaya Therapeutics' quarterly Gains from Investment Securities came in at $214737.0 in Q1 2026, down 85.36% year-on-year from $1.5 million in Q1 2025, and down 62.52% quarter-over-quarter from $573000.0 in Q4 2025.
Tenaya Therapeutics has reported Gains from Investment Securities for 7 years, with the latest figure at $214737.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 85.36% year-over-year to $214737.0; the trailing twelve-month figure through Mar 2026 stood at $214737.0 (down 85.36% YoY), and the FY2025 full-year result was $12.1 million, up 30.22% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $214737.0, down from $573000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $12.2 million in Q2 2025, with the low at -$875000.0 in Q4 2023.
- Average Gains from Investment Securities over 5 years is $2.4 million, with a median of $674900.0 recorded in 2024.
- Year-over-year, Gains from Investment Securities sank 111.74% in 2022 and soared 146735.3% in 2025.
- Tracing TNYA's Gains from Investment Securities over 5 years: stood at -$680000.0 in 2022, then retreated by 28.68% to -$875000.0 in 2023, then soared by 177.13% to $674900.0 in 2024, then retreated by 15.1% to $573000.0 in 2025, then sank by 62.52% to $214737.0 in 2026.
- The last three Gains from Investment Securities figures came in at $214737.0 (Q1 2026), $573000.0 (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 214,737.00 |
| Mar 31, 2026 | 214,737.00 |
| Dec 31, 2025 | 573,000.00 |
| Dec 31, 2025 | 573,000.00 |
| Sep 30, 2025 | 3.83 Mn |
| Sep 30, 2025 | 3.83 Mn |
| Jun 30, 2025 | 12.22 Mn |
| Jun 30, 2025 | 12.22 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 674,900.00 |
| Dec 31, 2024 | 674,900.00 |
| Sep 30, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 10.45 Mn |
| Jun 30, 2024 | 10.45 Mn |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -875,000.00 |
| Dec 31, 2023 | -875,000.00 |
| Sep 30, 2023 | 911,813.00 |
| Sep 30, 2023 | 911,813.00 |
| Jun 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 8.13 Mn |
| Mar 31, 2023 | 55,440.00 |
| Mar 31, 2023 | 55,440.00 |
| Dec 31, 2022 | -680,000.00 |
| Dec 31, 2022 | -680,000.00 |
| Sep 30, 2022 | 2.53 Mn |
| Sep 30, 2022 | 2.53 Mn |
| Jun 30, 2022 | 38,408.00 |
| Jun 30, 2022 | 38,408.00 |
| Mar 31, 2022 | -25,000.00 |
| Mar 31, 2022 | -25,000.00 |
| Dec 31, 2021 | -1.36 Mn |
| Dec 31, 2021 | -1.36 Mn |
| Sep 30, 2021 | 41,038.00 |
| Sep 30, 2021 | 41,038.00 |
| Jun 30, 2021 | 442.00 |
| Jun 30, 2021 | 442.00 |
| Mar 31, 2021 | 213,000.00 |
| Mar 31, 2021 | 213,000.00 |
| Dec 31, 2020 | 1.16 Mn |
| Dec 31, 2020 | 1.16 Mn |
| Sep 30, 2020 | -13,000.00 |
| Sep 30, 2020 | -13,000.00 |